Prospective study on outcome of MDR-TB using the shorter regimen during COVID-19 pandemic
Background: According to Indian TB report 2020, 66,225 MDR/RR-TB cases were detected in India, 56,569 (85%) were put on treatment, and 40,397 (75%) were initiated on shorter drug regimens at the time of diagnosis. In the absence of an effective vaccine, there is an urgent need for new treatment regi...
Saved in:
| Main Authors: | G Sravan Kumar, P Sameena, V Karthik, Nalini Ghanate |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2023-06-01
|
| Series: | Journal of Family Medicine and Primary Care |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jfmpc.jfmpc_1723_22 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pyrazinamide Resistance: A Major Cause of Switching Shorter to Longer Bedaquiline-based Regimens in Multidrug-resistant Tuberculosis Patients
by: Oki Nugraha Putra, et al.
Published: (2024-12-01) -
Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region
by: G.B. Migliori, et al.
Published: (2024-03-01) -
The efficacy of all-oral shorter MDR-TB and pre-XDR TB treatment in Russia
by: Anna Abramchenko, et al.
Published: (2024-12-01) -
Safety and Effectiveness of BPaL-Based Regimens to Treat Multidrug-Resistant TB: First Experience of an Italian Tuberculosis Referral Hospital
by: Gina Gualano, et al.
Published: (2024-12-01) -
Association between toxin-antitoxin system mutations and global transmission of MDR-TB
by: Yameng Li, et al.
Published: (2024-11-01)